Grants / Department of Defense / Defense Health Agency Contracting Activity - DHACA

HT942525MRPMALA: DoD Melanoma, Melanoma Academy Leadership Award

Closed Closed October 1, 2025 Opportunity HT942525MRPMALA ☆ Save

This grant is closed. A newer notice from the same program is open now: DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2). Status: Closes November 18, 2026 (11 days left). It is in our archive of Defense Health Agency Contracting Activity - DHACA notices from 2025.

• Total funding$1.8 million
• Expected awards1
• Cost sharingNot required
• Funding typeCooperative Agreement

Key dates

Who can apply

This opportunity was open to any type of organization.

• Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Most of the program's money (59% over five years) went to colleges and universities.
• No cost sharing or match is required.

What the grant funds

Summary: This funding opportunity announcement seeks to solicit a Director and Deputy Director to lead the Melanoma Research Program (MRP) Melanoma Academy. The Melanoma Academy is a unique, interactive virtual academy focused on bringing together established investigators and independent, early-career investigators (Scholars) to develop successful, highly productive melanoma researchers in a collaborative research and career development environment. Distinctive Features: This funding mechanism is a partnering mechanism, requiring an Initiating Principal Investigator (PI) who will serve as the Melanoma Academy Director and a Partnering PI who will serve as the Melanoma Academy Deputy Director. · Only the Initiating PI will submit a pre-application. Both PIs will need to submit full applications; the Partnering PI’s application is an abbreviated package. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot approximately $2.1 million (M) to fund approximately one Melanoma Academy Leadership Award application with combined direct cost cap of $1.3M. The maximum period of performance is 4 years. It is anticipated that awards made from this fiscal year 2025 (FY25) funding opportunity will be funded with FY25 funds, which will expire for use on September 30, 2031. Awards supported with FY25 funds will be made no later than September 30, 2026.

Category: Science and Technology and other Research and Development.

Applying now

This notice no longer takes applications. Apply under the newer notice, HT942526BCRPCREA2, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.